Photo of Sherri-Ann M. Burnett-Bowie, MD, MPH

Sherri-Ann M. Burnett-Bowie, MD, MPH

  • Director, Multicultural Affairs


Accepting New Patients





Centers & Specialties

Cancer Center

Clinical Interests
  • Osteoporosis
  • Hypercalcemia
  • Hypocalcemia
  • Hypophosphatemia
  • Vitamin D deficiency
  • Adrenal nodules
  • Adrenal disorders
  • Hyperthyroidism
  • Hypothyroidism
  • Kidney stones
Medical Education
  • MPH, Harvard School of Public Health
  • MD, University of Pittsburgh School of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital
Board Certifications
  • Endocrinology
  • Diabetes & Metabolism
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Connecticut
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Sherri-Ann M. Burnett-Bowie MD, MPH is an Assistant Professor of Medicine at Harvard Medical School and a clinical investigator in the Massachusetts General Hospital (MGH) Endocrine Unit, where her research focuses on defining the physiology of a new mineral metabolism hormone, FGF23; skeletal and non-skeletal effects of vitamin D; and clinical trials of treatments for osteoporosis.  She cares for patients seen at the MGH Endocrine Associates and the MGH Bone Density Center.  Dr. Burnett-Bowie is an Associate Director of the MGH Multicultural Affairs Office and the Director for Multicultural Affairs for the Department of Medicine at MGH.  Teaching and increasing diversity and inclusivity are central to her mission.

Edit Profile

Research & Publications

Research Summary
Her research is focused on defining the physiology of a new phosphate-regulating hormone, FGF23, skeletal and non-skeletal consequences of vitamin D deficiency, and clinical trials of treatments for osteoporosis.
  1. Burnett, SM, S Gunawardene, FR Bringhurst et al.  Regulation of c-terminal and intact FGF23 by dietary phosphate in men and women.  JBMR 2006.
  2. Burnett-Bowie, SM , BZ Leder, MP Henao et al. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. CJASN 2012.
  3. Mitchell, DM, MP Henao, JS Finkelstein, SM Burnett-Bowie. Prevalence & predictors of vitamin D deficiency in healthy adults. JCEM 2012.
  4. Tsai, JN, Uihlein, AV, H Lee et al. Teriparatide & denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet 2013
  5. Finkelstein , JS, H. Lee, SM Burnett-Bowie et al. Gonadal steroids & body composition, strength, and sexual function in men. NEJM 2013

Edit Profile

News & Events


Endocrine Associates
15 Parkman Street
Boston MA, 02114-3117
Phone: 617-726-8720
Fax: 617-724-2718

Edit Profile

Back to Top